Core Viewpoint - Smith+Nephew has launched the TRIGEN MAX Tibia Nailing System, which features side-specific nails and variable angle locking technology, aimed at improving fracture fixation for tibia fractures [1][4]. Product Features - The TRIGEN MAX system is designed for both stable and unstable tibia fractures, offering trauma surgeons the option of right and left side-specific nails to optimize screw trajectories and minimize soft tissue irritation [1][4]. - The system includes a two-piece modular drop system for better visualization and ancillary instrument use, a 12.5mm channel reamer for tibia to preserve entry point integrity, and 5.0mm Lag Screws that streamline the workflow by compressing fractures in one insertion step [5]. Market Position - The TRIGEN MAX Tibia Nailing System is positioned as the next flagship product for Smith+Nephew, building on over two decades of proven performance from the TRIGEN Nails family [3][4]. - The system is currently available only in the United States, indicating a focused market entry strategy [6]. Company Overview - Smith+Nephew is a global medical technology company with a mission to restore people's bodies and self-belief through innovative technologies, operating in approximately 100 countries and generating annual sales of $5.8 billion in 2024 [7][8].

Core Viewpoint - Smith+Nephew has launched the TRIGEN MAX Tibia Nailing System, which features side-specific nails and variable angle locking technology, aimed at improving fracture fixation for tibia fractures [1][4][5]. Product Features - The TRIGEN MAX Tibia Nailing System offers trauma surgeons the option of side-specific nails for optimized screw trajectories, enhancing fragment fixation and reducing soft tissue irritation [1][5]. - The system includes a two-piece modular drop system for better visualization and ancillary instrument use, a 12.5mm channel reamer designed to protect soft tissue, and 5.0mm Lag Screws that streamline the workflow by compressing fractures in one insertion step [6]. Market Position - The TRIGEN MAX Tibia Nailing System is positioned as the next flagship product for Smith+Nephew, building on over two decades of proven performance in the TRIGEN Nails family [4]. - The system is currently available only in the United States, indicating a focused market entry strategy [7]. Company Overview - Smith+Nephew is a global medical technology company focused on the repair, regeneration, and replacement of soft and hard tissue, with annual sales of $5.8 billion in 2024 [9]. - The company operates in approximately 100 countries and is a constituent of the FTSE100 [9].